AEHR vs TER: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

TER is the larger of the two ($37.89B market cap): the incumbent the market prices for continued execution (20.24x forward earnings, beta 1.75). AEHR is the smaller challenger ($1.95B), actually pricier on forward earnings (35.31x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

AEHR vs TER: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricAEHRTERWhat it tells you
Market cap$1.95B$37.89BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E35.3120.24Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Beta3.331.75Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range32% of range27% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book8.7410.28How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: TER is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how AEHR and TER affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AEHR and TER share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AEHR and TER exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Aehr Test Systems (AEHR) do?

Aehr Test Systems, headquartered in Fremont, California, designs and sells semiconductor test and burn-in equipment. Its FOX-P platform (FOX-XP and FOX-NP systems, plus WaferPak full-wafer contactors and DiePak carriers) performs wafer-level and singulated-die test, burn-in, and stabilization, processes that stress chips at elevated voltage and temperature to weed out early-life failures before the parts reach customers. Aehr also added ultra-high-power Sonoma systems for package-level burn-in of high-wattage devices. The company is one of the few suppliers offering both wafer-level and package-level burn-in across silicon carbide, gallium nitride, AI processors, silicon photonics, and flash memory.

Full AEHR guide

What does Teradyne (TER) do?

Teradyne designs and sells automated test equipment (ATE) used to verify that semiconductors work before they ship. Its largest business, Semiconductor Test, sells systems like the UltraFLEX and J750 platforms that test system-on-chip (SoC) and memory devices, including the high bandwidth memory and compute processors that power AI data centers. The company makes money mostly from selling these test systems plus recurring service, software, and consumables. Beyond chip test, Teradyne runs a Robotics segment built around Universal Robots (collaborative robot arms) and Mobile Industrial Robots (MiR autonomous mobile robots), plus a smaller Product Test unit, giving it exposure to factory and warehouse automation alongside the core test franchise.

Full TER guide

AEHR vs TER: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • AEHR drivers: AI and data center diversification; Silicon photonics and optical interconnect.
  • TER drivers: AI compute and HBM test demand; Memory and HBM share gains.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Customer concentration is heavy: a small number of large semiconductor manufacturers drive most revenue, and the AI story leans on one lead hyperscale customer, so the loss or delay of a single program can swing results materially. For TER, semiconductor test equipment is one of the most cyclical corners of the chip industry, and Teradyne's revenue can swing materially as customers add or pause capacity.

AEHR or TER: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick AEHR if you believe its drivers more; TER if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AEHR and TER guides.

AEHR vs TER: the full fundamentals

AEHR. Aehr swung back to a quarterly profit in fiscal Q4 2026, beating the consensus estimate, but the full fiscal year was still a loss on about $50 million of revenue. The roughly $2.1 billion market value prices in analyst expectations of about $136 million of revenue in fiscal 2027, and the stock has fallen about 34% over three months even after a 193% gain year to date. The next check is fiscal Q1 2027 results on November 2, 2026, where consensus sits near $26.6 million of revenue and $0.09 per share. All figures are approximate as of October 16, 2026.

TER. As of October 16, 2026, Teradyne trades near $334, about 46 times trailing and 29 times forward earnings and about 11.7 times trailing sales, a premium to the broader semiconductor group that reflects AI-driven growth of roughly 100 percent in the June quarter. The multiple has come down from earlier in 2026 as earnings rose and the stock pulled back from its high near $488. The analyst mean target is about $446, and third-quarter results on October 27 are the next checkpoint.

Headline figures (approximate, October 2026): AEHR shows share price / market cap ~$64.93 (Oct 16, 2026), ~$2.1 billion, revenue (fy2026, ended may 2026) ~$50 million; fiscal Q4 ~$18.8 million, up ~34% year over year, net income FY2026 net loss ~$7.1 million (EPS ~-$0.23); fiscal Q4 profit ~$1.4 million, EPS $0.11 vs ~-$0.01 expected, margins (ttm) ~35% gross, ~-6% operating; TER shows revenue (ttm) ~$4.46 billion, q2 2026 revenue ~$1.33 billion (up ~104% year over year), gross margin (ttm) ~59%, operating margin ~33%, net income (ttm) ~$1.15 billion.

The bottom line: AEHR vs TER

AEHR and TER are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AEHR and TER exposure against your real portfolio. It is not an investment adviser.

Wondering how AEHR or TER fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Aehr Test Systems

Ask Walnut's AI anything about AEHR and see how it fits what you own.

FAQ

What is the difference between AEHR and TER?

+

Aehr Test Systems, headquartered in Fremont, California, designs and sells semiconductor test and burn-in equipment. Teradyne designs and sells automated test equipment (ATE) used to verify that semiconductors work before they ship. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is AEHR or TER the better stock?

+

Neither is universally better. TER is the larger incumbent; AEHR is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, AEHR or TER?

+

On forward P/E (as of November 2026), AEHR trades at 35.31x and TER at 20.24x, so TER is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both AEHR and TER?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of AEHR vs TER?

+

AEHR: Customer concentration is heavy: a small number of large semiconductor manufacturers drive most revenue, and the AI story leans on one lead hyperscale customer, so the loss or delay of a single program can swing results materially. Competition concerns flared in October 2026 when Teradyne introduced its Titan HP platform and Aehr shares fell; Oppenheimer argued the two address different test stages (system-level test versus wafer-level burn-in), but the episode shows how sensitive the valuation is. The electric-vehicle and silicon carbide demand that powered prior years has softened, and management has stayed conservative about a SiC recovery. As a small-cap capital-equipment supplier, Aehr's orders are lumpy and tied to customers' capex cycles, which produced a fiscal 2026 net loss of about $7 million. The valuation is demanding: around 42 times trailing sales and about 47 times forward earnings, priced for the AI ramp to arrive roughly on schedule. The stock's 52-week range of about $18.70 to $147.40 shows how violently it can move in both directions. TER: Semiconductor test equipment is one of the most cyclical corners of the chip industry, and Teradyne's revenue can swing materially as customers add or pause capacity. The customer base is concentrated, so a handful of large memory and compute customers drive a large share of orders, and an order delay at any of them can dent a quarter. The robotics business is growing but still small and has historically ramped slowly, so it cannot fully offset a test downturn. Teradyne also competes directly with Advantest, which leads the broader ATE market, so share shifts and pricing pressure are ongoing risks. After a large run-up the shares carry an elevated valuation (about 46 times trailing and 29 times forward earnings as of October 2026), which leaves less margin for error if AI test demand normalizes; the roughly 10 percent drop in the month to October 16 shows how quickly that can reverse. Consensus also calls for September-quarter revenue below the June quarter, so the October 27 report will be read for whether that dip is a pause or a peak.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AEHR or TER; figures are approximate and dated (as of November 2026). Verify current data before investing.